Top News

Second Sight Medical Files For IPO

Sylmar-based Second Sight Medical, a medical devices maker developing treatments for outer retinal degenerations, such as retinitis pigmentosa, filed for an IPO this week, saying that it is looking to raise up to $45M in an IPO on the Nasdaq Capital Market. The IPO is being underwritten by MDB Capital Group. The company said it expects to offer its stock at $9.00 per share, trading under the symbol EYES. Second Sight Medical is backed by medical devices mogul Alfred E. Mann.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel